12:00 AM
 | 
Jul 09, 2012
 |  BC Week In Review  |  Company News  |  Deals

Affitech, IBC Generium deal

Affitech's Affitech Research A/S subsidiary and IBC Generium signed a binding term sheet to grant IBC a license to Affitech's Molecular Based Antibody Screening (MBAS) technology and phage antibody libraries. Affitech will receive an upfront payment and will be eligible for payment upon...

Read the full 193 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >